The apolipoprotein receptor LRP3 compromises APP levels

• Published in: Alzheimer's research & therapy Vol. 13; no. 1; pp. 181 - 17
• Main Authors: Cuchillo-Ibañez, Inmaculada, Lennol, Matthew P., Escamilla, Sergio, Mata-Balaguer, Trinidad, Valverde-Vozmediano, Lucía, Lopez-Font, Inmaculada, Ferrer, Isidro, Sáez-Valero, Javier
• Format: Journal Article
• Language: English
• Published: London BioMed Central 02.11.2021; BioMed Central Ltd; Springer Nature B.V; BMC
• Subjects: Alzheimer Disease; Alzheimer Disease - genetics; Alzheimer's disease; Amyloid beta-Peptides; Amyloid beta-protein; Amyloid beta-Protein Precursor; Amyloid beta-Protein Precursor - genetics; Animals; ApoER2; ApoER2-ICD; Apolipoproteins; Beta-amyloid; Biomedical and Life Sciences; Biomedicine; Brain; Chloroquine; Cognitive ability; Development and progression; Gene expression; Genetic aspects; Geriatric Psychiatry; Geriatrics/Gerontology; Health aspects; Humans; LDL-Receptor Related Proteins; LDL-Receptor Related Proteins - genetics; Life Sciences; Low density lipoprotein receptors; Middle age; Middle Aged; Neurological research; Neurology; Neurosciences; Pathology; Peptides; Reelin Protein; sAPP; Sucrose; Spain; United States > US; Alzheimer’s disease; Chloroquine; Beta-amyloid; ApoER2-ICD; sAPP; ApoER2; Differential centrifugation; Autophagy
• ISSN: 1758-9193; 1758-9193
• DOI: 10.1186/s13195-021-00921-5

Background Members of the low-density lipoprotein (LDL) receptor family are involved in endocytosis and in transducing signals, but also in amyloid precursor protein (APP) processing and β-amyloid secretion. ApoER2/LRP8 is a member of this family with key roles in synaptic plasticity in the adult brain. ApoER2 is cleaved after the binding of its ligand, the reelin protein, generating an intracellular domain (ApoER2-ICD) that modulates reelin gene transcription itself. We have analyzed whether ApoER2-ICD is able to regulate the expression of other LDL receptors, and we focused on LRP3, the most unknown member of this family. We analyzed LRP3 expression in middle-aged individuals (MA) and in cases with Alzheimer’s disease (AD)-related pathology, and the relation of LRP3 with APP. Methods The effects of full-length ApoER2 and ApoER2-ICD overexpression on protein levels, in the presence of recombinant reelin or Aβ42 peptide, were evaluated by microarray, q RT-PCRs, and western blots in SH-SY5Y cells. LRP3 expression was analyzed in human frontal cortex extracts from MA subjects (mean age 51.8±4.8 years) and AD-related pathology subjects [Braak neurofibrillary tangle stages I–II, 68.4±8.8 years; III–IV, 80.4 ± 8.8 years; V–VI, 76.5±9.7 years] by q RT-PCRs and western blot; LRP3 interaction with other proteins was assessed by immunoprecipitation. In CHO cells overexpressing LRP3, protein levels of full-length APP and fragments were evaluated by western blots. Chloroquine was employed to block the lysosomal/autophagy function. Results We have identified that ApoER2 overexpression increases LRP3 expression, also after reelin stimulation of ApoER2 signaling. The same occurred following ApoER2-ICD overexpression. In extracts from subjects with AD-related pathology, the levels of LRP3 mRNA and protein were lower than those in MA subjects. Interestingly, LRP3 transfection in CHO-PS70 cells induced a decrease of full-length APP levels and APP-CTF, particularly in the membrane fraction. In cell supernatants, levels of APP fragments from the amyloidogenic (sAPPα) or non-amyloidogenic (sAPPβ) pathways, as well as Aβ peptides, were drastically reduced with respect to mock-transfected cells. The inhibitor of lysosomal/autophagy function, chloroquine, significantly increased full-length APP, APP-CTF, and sAPPα levels. Conclusions ApoER2/reelin signaling regulates LRP3 expression, whose levels are affected in AD; LRP3 is involved in the regulation of APP levels.